Free Trial

Cross Country Healthcare (NASDAQ:CCRN) Trading Up 2.8%

Cross Country Healthcare logo with Business Services background

Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) rose 2.8% on Wednesday . The company traded as high as $15.22 and last traded at $15.17. Approximately 33,627 shares traded hands during trading, a decline of 92% from the average daily volume of 430,910 shares. The stock had previously closed at $14.75.

Analyst Ratings Changes

CCRN has been the topic of a number of research reports. Truist Financial boosted their price objective on Cross Country Healthcare from $16.00 to $17.00 and gave the stock a "hold" rating in a research report on Thursday, August 1st. Benchmark reduced their price objective on Cross Country Healthcare from $21.00 to $19.00 and set a "buy" rating on the stock in a research report on Thursday, May 2nd. Finally, Barrington Research reduced their price objective on Cross Country Healthcare from $21.00 to $19.00 and set an "outperform" rating on the stock in a research report on Thursday, August 8th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $19.60.

Get Our Latest Research Report on Cross Country Healthcare

Cross Country Healthcare Stock Performance

The stock has a market capitalization of $521.96 million, a price-to-earnings ratio of 11.55, a P/E/G ratio of 2.57 and a beta of 0.63. The company has a fifty day simple moving average of $14.87 and a 200 day simple moving average of $16.19.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its earnings results on Wednesday, July 31st. The business services provider reported $0.10 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.04). The company had revenue of $339.77 million for the quarter, compared to analyst estimates of $334.75 million. Cross Country Healthcare had a return on equity of 7.29% and a net margin of 0.54%. The firm's quarterly revenue was down 37.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.69 earnings per share. As a group, equities analysts predict that Cross Country Healthcare, Inc. will post 0.68 earnings per share for the current fiscal year.


Insiders Place Their Bets

In related news, insider Marc S. Krug sold 13,657 shares of the company's stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $14.82, for a total transaction of $202,396.74. Following the sale, the insider now owns 36,020 shares in the company, valued at approximately $533,816.40. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, insider Marc S. Krug sold 13,657 shares of Cross Country Healthcare stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $14.82, for a total value of $202,396.74. Following the completion of the sale, the insider now owns 36,020 shares in the company, valued at approximately $533,816.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Karen Mote sold 13,829 shares of Cross Country Healthcare stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $17.08, for a total transaction of $236,199.32. Following the completion of the sale, the insider now owns 24,696 shares of the company's stock, valued at approximately $421,807.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 29,431 shares of company stock valued at $472,070. 4.90% of the stock is currently owned by company insiders.

Institutional Trading of Cross Country Healthcare

Several hedge funds have recently modified their holdings of CCRN. GAMMA Investing LLC bought a new stake in shares of Cross Country Healthcare in the 4th quarter valued at $28,000. Gladius Capital Management LP increased its stake in shares of Cross Country Healthcare by 37.1% in the 4th quarter. Gladius Capital Management LP now owns 1,902 shares of the business services provider's stock valued at $43,000 after acquiring an additional 515 shares in the last quarter. nVerses Capital LLC bought a new stake in Cross Country Healthcare during the 2nd quarter valued at $50,000. Denali Advisors LLC increased its stake in Cross Country Healthcare by 3,885.5% during the 1st quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider's stock valued at $103,000 after purchasing an additional 5,362 shares in the last quarter. Finally, EMC Capital Management bought a new stake in Cross Country Healthcare during the 1st quarter valued at $155,000. Institutional investors own 96.03% of the company's stock.

Cross Country Healthcare Company Profile

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Read More

→ Forget Trump and Kamala (From Investors Alley) (Ad)

Should you invest $1,000 in Cross Country Healthcare right now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines